Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

STEP12

Novo Nordisk · Phase 3 · Completed · Enrollment 242

NCT06041217

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutide 2.4 milligram (mg)n/rn/rn/rn/rn/r
Placebo2 participants0 participants6 participantsn/r0
Semaglutide 2.4 mg29 participants16 participants30 participantsn/r0

A count stays a count. This page does not turn a count into a percent.